Veterinary Healthcare Market Report 2026

The veterinary healthcare market size has grown strongly in recent years. It will grow from $223.37 billion in 2025 to $238.94 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increase in pet ownership rates, growth in livestock production and health management, expansion of veterinary hospitals and clinics, rising awareness of zoonotic diseases, availability of basic veterinary medicines and services.

The veterinary healthcare market size is expected to see strong growth in the next few years. It will grow to $315.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growth in pet humanization trends, increasing expenditure on animal health, advancements in veterinary diagnostics and treatments, rising demand for preventive healthcare programs, expansion of specialty and emergency veterinary services. Major trends in the forecast period include rising demand for preventive and wellness care, expansion of companion animal healthcare services, growing adoption of advanced diagnostic and imaging services, increasing focus on infectious disease control and biosecurity, higher spending on specialized and emergency veterinary care.

The increasing prevalence of zoonotic diseases is expected to drive the growth of the veterinary healthcare market in the coming years. Zoonotic diseases include illnesses and infections that can be transmitted between animals and humans, either directly or indirectly. The rise in zoonotic disease cases is largely attributed to increased human-animal interactions, as the expansion of livestock farming and closer proximity between humans and animals create more opportunities for pathogens to transfer from animals to people. Veterinary healthcare plays a critical role in preventing and managing zoonotic diseases by monitoring animal health and implementing measures that reduce transmission risks to humans. For example, in December 2024, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, there were 148,181 reported human cases of campylobacteriosis, up from 139,225 in 2022, along with increases in salmonellosis and STEC infections, indicating a broader upward trend in zoonotic diseases. The veterinary healthcare market supports this need by providing essential preventive services, diagnostics, and treatments for animals, thereby lowering transmission risks through vaccination programs, disease surveillance, and client education. Therefore, the rising prevalence of zoonotic diseases is contributing to the expansion of the veterinary healthcare market.

Major companies operating in the veterinary healthcare market are focusing on the development of innovative solutions such as electronic prescribing (e-prescribing) platforms for veterinary medications to address the growing demand for faster access to medicines, improved prescription accuracy, enhanced patient safety, and more efficient clinical workflows. E-prescribing platforms enable veterinarians to transmit prescriptions electronically to pharmacies, minimizing errors associated with handwritten prescriptions, phone-based orders, and fax communications, while also allowing real-time checks for drug interactions and patient history. This offers a significant advantage over traditional paper-based prescribing methods. For instance, in July 2024, Surescripts LLC, a U.S.-based health information network, expanded its e-prescribing services to include veterinary medications through a partnership with DAW Systems Inc. (ScriptSure). This solution enables secure electronic transmission of veterinary prescriptions to retail pharmacies, improving workflow efficiency by automating prescription processing, reducing administrative workload, enhancing medication adherence for pets, and supporting safer veterinary care through integrated alerts and verification tools, ultimately leading to better health outcomes for animal patients.

In April 2023, Mars Incorporated, a U.S.-based global provider of pet care products and services across nutrition, diagnostics, technology, and veterinary healthcare, acquired Heska Corporation for an undisclosed amount. Through this acquisition, Mars sought to expand access to advanced veterinary diagnostics and specialty products, accelerate research and development initiatives, and strengthen its global veterinary healthcare presence by integrating Heska’s technology-driven solutions into the Mars Petcare Science & Diagnostics division. Heska Corporation is a U.S.-based company specializing in advanced veterinary diagnostic instruments, specialty veterinary products, and comprehensive solutions for animal health professionals worldwide.

Major companies operating in the veterinary healthcare market are Veterinary Healthcare, Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co Inc., IDEXX Laboratories Inc., Evonik Industries AG, Patterson Companies Inc., Ceva Animal Health LLC, Pets at Home Group PLC, National Veterinary Associates Inc., Phirbo Animal Health, MSD Animal Health UK Ltd., C.H. Boehringer Sohn AG & Co, Eli Lilly and Company, Vetoquinol India Animal Health Pvt Ltd., Virbac Group, Dechra Pharmaceuticals plc, Heska Corp, Phillip Brothers Chemicals Inc., Neogen Corp, Kindred Biosciences Inc., Animalcare Group plc, Biogenesis Bago Saude Animal Ltd., Nexvet Biopharma plc, Norbrook Laboratories Ltd., Ouro Fino Saude Animal Participacoes SA, PetIQ Inc., Veterinary Centers of America. Clinical Veterinary Labs, Inc., Greencross Pty Ltd., Consumer Value Stores Group plc, Independent Vetcare Ltd., AniCura AB, VetPartners UK Holdings Ltd., VetCor Professional Practices LLC.

North America was the largest region in the veterinary healthcare market in 2025. Asia-Pacific was the second-largest region in the veterinary healthcare market. The regions covered in the veterinary healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary healthcare market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs have affected the veterinary healthcare market by increasing costs of imported medical equipment, diagnostic devices, pharmaceuticals, and consumables used in animal care. These impacts are most visible in advanced diagnostic equipment and specialized medicines, particularly across North America, Europe, and Asia-Pacific where global sourcing is common. Higher operational costs may slow adoption among small and mid-sized clinics. However, tariffs are also encouraging local manufacturing of veterinary equipment and medicines, strengthening regional supply chains and supporting long-term market sustainability.

The veterinary healthcare market research report is one of a series of new reports that provides veterinary healthcare market statistics, including veterinary healthcare industry global market size, regional shares, competitors with a veterinary healthcare market share, detailed veterinary healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary healthcare industry. This veterinary healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary healthcare pertains to a range of healthcare services that encompass the diagnosis, treatment, and prevention of diseases in animals. It also includes the responsibilities of individuals dedicated to providing medical care to sick or injured animals, as well as implementing measures to reduce the transmission of infectious diseases among pets.

The primary categories within veterinary healthcare encompass veterinary services, veterinary medical equipment, and animal medicine. These services and products cater to a variety of animals, including dogs and cats, horses, ruminants, swine, poultry, and various other animals. Veterinary services involve the provision of healthcare services for animals, while the products encompass instruments, equipment, and disposables used in the veterinary field.

The veterinary healthcare market includes revenues earned by entities by providing treatment for diseases that influence the health of domestic and wild animals and must be prevented, controlled, diagnosed, and treated, along with the human transmission of animal diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.